Avycaz 2.5 gram vials
Ended Awarded Last action
- Contract number
- SPE2DR26F20PH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,057
Award facts
- Contract value 100% obligated
- $18,057.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,057.17 to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, for the supply of AVYCAZ 2.5 gram vials, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The awardee, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. This delivery order was issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies.
Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. (UEI: NWEGNLYTBDW4), which also maintains a significant IDC with the Defense Logistics Agency valued up to $999,999,999.00 through December 31, 2031. AVYCAZ (ceftazidime-avibactam) is a broad-spectrum antibiotic used in treating serious bacterial infections, including gram-negative infections resistant to other antimicrobials, making it a critical pharmaceutical commodity for military healthcare programs. The rapid completion timeline reflects the urgent medical supply needs typical of federal government healthcare operations supporting defense and veteran populations worldwide.
Quick answers
Who was awarded contract SPE2DR26F20PH?
SPE2DR26F20PH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F20PH worth?
The government has obligated $18,057 on SPE2DR26F20PH.
Is contract SPE2DR26F20PH an order under another contract?
Yes. SPE2DR26F20PH is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20PH competed?
The extent of competition for SPE2DR26F20PH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award